Results 261 to 270 of about 10,214,758 (341)

Cardiometabolic Co-morbidity Burden and Circulating Biomarkers in Patients With Chronic Coronary Disease in the ISCHEMIA Trials. [PDF]

Am J Cardiol
Hamo CE, Liu R, Wu W, Anthopolos R, Bangalore S, Held C, Kullo I, Mavromatis K, McManus B, Newby LK, Reynolds HR, Ruggles KV, Wallentin L, Maron DJ, Hochman JS, Newman JD, Berger JS, ISCHEMIA Biorepository Research Group.   +17 more
europepmc   +1 more source

The use of a large industrial population to study the effects of social and behavioral factors on coronary heart disease.

, 1966
Lawrence E. Hinkle
openalex   +2 more sources

Lung‐Penetrating Biomimetic Extracellular Vesicle Spherical Nucleic Acids for Pulmonary Fibrosis Therapy Through ROS Scavenging and Anti‐Inflammatory Effects

Aggregate, EarlyView.
This work describes a biomimetic extracellular vesicle‐spherical nucleic acid (BEV‐SNA) platform for idiopathic pulmonary fibrosis (IPF) therapy. BEV‐SNA is composed of mechanically extruded BEVs from primary MSCs and cholesterol‐modified ssDNA that are assembled through hydrophobic interactions.
Saiyun Lou, Jiangpo Ma, Pan Fu, Lin Li, Jingyun Huang, Fangxue Jing, Yuhui Wang, Sihua Qian, Jianping Zheng, Jiang Li, Zhaoxing Dong, Kaizhe Wang   +11 more
wiley   +1 more source

Colchicine improves clinical outcomes in patients with coronary disease, will it result in similar benefits in peripheral artery disease? [PDF]

Eur Heart J Open
Tardif JC, Cuthill S.
europepmc   +1 more source

The anti-coronary club. A dietary approach to the prevention of coronary heart disease--a seven-year report.

, 1966
George Christakis, Seymour H. Rinzler, Morton Archer, Gerald R. Winslow, S Jampel, Jessica M. Stephenson, Gary H. Friedman, Henry G. Fein, A. Kraus, George James   +9 more
openalex   +2 more sources

Tau Amyloid Corona‐Shelled Nanoparticle‐Based Drug Screening Platform for Discovering Tau Oligomer‐Degrading Drugs

Aggregate, EarlyView.
Tau amyloid corona‐shelled nanoparticles (TACONs) were synthesized by incubating gold nanoparticles (AuNPs) with tau monomers that had been pre‐reacted with heparin. These TACONs represent a promising high‐throughput screening platform for identifying tau oligomer degraders as potential therapeutic agents for Alzheimer's disease.
Hyo Gi Jung, Dongsung Park, Junho Bang, Yeon Ho Kim, Jae Won Jang, Yonghwan Kim, Hyunji Kim, Seungmin Lee, Wonbin Moon, Kyo Seon Hwang, Jeong Hoon Lee, Dongtak Lee, Dae Sung Yoon   +12 more
wiley   +1 more source

Variation in Health Status With Invasive vs Conservative Management of Chronic Coronary Disease. [PDF]

J Am Coll Cardiol
Arnold SV, Jones PG, Maron DJ, Cohen DJ, Mark DB, Reynolds HR, Bangalore S, Chen J, Newman JD, Harrington RA, Stone GW, Hochman JS, Spertus JA, ISCHEMIA Research Group.   +13 more
europepmc   +1 more source

Illuminating the Unseen and Targeting the Untreatable: Aggregation‐Induced Emission Nanoparticles as Intelligent, Immune‐Compatible Tools for Precision Cancer Theranostics

Aggregate, EarlyView.
Rationally engineered AIE nanoparticles can unite deep‐tissue imaging, photodynamic therapy, photothermal therapy, and immune microenvironment reprogramming. Through precise photophysical tuning and targeted delivery, these intelligent nanoplatforms enable real‐time monitoring, potent tumor eradication, and immune activation, offering a versatile and ...
Quazi T. H. Shubhra, Robert Musiol, Huachun Pan, Qiang Cai, Xiaosong He, Xiaojun Cai   +5 more
wiley   +1 more source

Functional myocardial assessment in cine cardiac computerized tomographic angiography using echocardiographic feature-tracking software in patients with and without significant coronary disease. [PDF]

Int J Cardiol Heart Vasc
Hertz A, Jerdev M, Grosman-Rimon L, Ben-Zakai I, Rimon J, Amir O, Greener GE, Carasso S.   +7 more
europepmc   +1 more source

Design, Control, and Clinical Applications of Magnetic Actuation Systems: Challenges and Opportunities

Advanced Intelligent Systems, Volume 7, Issue 3, March 2025.
This review aims to provide a broad understanding for interdisciplinary researchers in engineering and clinical applications. It addresses the development and control of magnetic actuation systems (MASs) in clinical surgeries and their revolutionary effects in multiple clinical applications.
Yingxin Huo, Lidong Yang, Tiantian Xu, Dong Sun   +3 more
wiley   +1 more source